Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants	Units counted
Overall Study	STARTED	Sham Treatment	133	133
Overall Study	STARTED	Intravitreal Aflibercept Injection (IAI) 2Q16	135	135
Overall Study	STARTED	Intravitreal Aflibercept Injection (IAI) 2Q8	134	134
Overall Study	Completed Week 52	Sham Treatment	109	109
Overall Study	Completed Week 52	Intravitreal Aflibercept Injection (IAI) 2Q16	122	122
Overall Study	Completed Week 52	Intravitreal Aflibercept Injection (IAI) 2Q8	124	124
Overall Study	COMPLETED	Sham Treatment	97	97
Overall Study	COMPLETED	Intravitreal Aflibercept Injection (IAI) 2Q16	111	111
Overall Study	COMPLETED	Intravitreal Aflibercept Injection (IAI) 2Q8	112	112
Overall Study	NOT COMPLETED	Sham Treatment	36	36
Overall Study	NOT COMPLETED	Intravitreal Aflibercept Injection (IAI) 2Q16	24	24
Overall Study	NOT COMPLETED	Intravitreal Aflibercept Injection (IAI) 2Q8	22	22

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02718326/flow